TREA

90727451 - SEACROSS

Follow

Information

  • Trademark
  • 90727451
  • Serial Number
    90727451
  • Registration Number
    6976777
  • Filing Date
    May 21, 2021
    3 years ago
  • Registration Date
    February 14, 2023
    2 years ago
  • Transaction Date
    February 18, 2023
    a year ago
  • Status Date
    February 14, 2023
    2 years ago
  • Published for Opposition Date
    November 29, 2022
    2 years ago
  • Location Date
    February 14, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MCCARTHY, JOSEPH PATRI
  • Attorney Docket Number
    55709000001
    Attorney Name
    Michael J. Turgeon
    Law Office Assigned Location Code
    N90
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
SEACROSS
Case File Statements
  • DM0000: The mark consists of the stylized term "SEACROSS".
  • GS0051: Chemical contraceptives; drugs for medical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; bacterial preparations for medical and veterinary use; bouillons for bacteriological cultures; biochemical medicines, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; prepared Chinese medicine, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; antibiotics; diagnostic preparations for medical purposes; medicines for human purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; medicines for dental purposes; chemical preparations for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; chemical preparations for pharmaceutical purposes, namely, contrast agents; chemical preparations for pharmaceutical purposes, namely, antidote; syrups for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; capsules for medicines, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; pharmaceutical preparations, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; chemico-pharmaceutical preparations, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; collyrium; biological preparations for medical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; lotions for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; medicinal tea; vaccines; food for babies; dietetic substances being fatty milk, omega-3 fish oil, amino acids, glucose, electrolytes, proteins, fats, carbohydrates, vitamins, trace elements, dietary fiber, and unsaturated fatty acids, all adapted for medical use; nutritional supplements; air purifying preparations; protein supplements for animals; medicines for veterinary purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; pesticides; dressings, medical; dental lacquer
  • PM0001: SEA CROSS
Case File Event Statements
  • 2/14/2023 - 2 years ago
    17 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 2/14/2023 - 2 years ago
    16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/29/2022 - 2 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/29/2022 - 2 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/9/2022 - 2 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/26/2022 - 2 years ago
    12 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 10/21/2022 - 2 years ago
    11 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 10/17/2022 - 2 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/26/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/26/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/26/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/7/2022 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/7/2022 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/7/2022 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/2/2022 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/18/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/25/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP